| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
TABLE 1: FULL-YEAR 2024 GUIDANCE2 Previous Guidance Current
|
TABLE 1: FULL-YEAR 2024 GUIDANCE2 |
||||
|
Previous Guidance |
Current Guidance |
|||
|
Sales |
$38.5B - $39.3B |
$39.1B - $39.7B |
||
|
Organic1 Growth |
4% - 6% |
5% - 6% |
||
|
Segment Margin |
23.8% - 24.1% |
23.3% - 23.5% |
||
|
Expansion |
Up 30 - 60 bps |
Down 20 - Flat bps |
||
|
Adjusted Earnings Per Share3 |
$10.15 - $10.45 |
$10.05 - $10.25 |
||
|
Adjusted Earnings Growth3 |
7% - 10% |
6% - 8% |
||
|
Operating Cash Flow |
$6.7B - $7.1B |
$6.6B - $7.0B |
||
|
Free Cash Flow1 |
$5.6B - $6.0B |
$5.5B - $5.9B |
||
Posted In: HON
